SCHEMBL469375

SCHEMBL469375

COC(=O)C(C)n1ccc(N)nc1=O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.35
HPGD P15428 1/20 0.35
SLC22A6 Q4U2R8 1/20 0.34
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
POLB P06746 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
XIAP P98170 1/20 0.34
BIRC2 Q13490 1/20 0.34
EP300 Q09472 2/20 0.33
LMNA P02545 1/20 0.32
THRB P10828 1/20 0.32
MTOR P42345 1/20 0.32
MDM2 Q00987 1/20 0.32
NCOA1 Q15788 1/20 0.32
NCOA3 Q9Y6Q9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL455007 0.83 USP5 (0.40) FGFR1SLC22A6KDM4EALDH1A1MAPT
SCHEMBL24082118 0.78 FGFR1 (0.35) FGFR1SLC22A6ALDH1A1MAPTLMNA
SCHEMBL9151037 0.77 FGFR1 (0.40) FGFR1SLC22A6ALDH1A1MAPTXIAP
SCHEMBL784164 0.77 ADORA2A (0.36) FGFR1SLC22A6ALDH1A1MAPTXIAP
SCHEMBL21173553 0.76 FGFR1 (0.35) FGFR1SLC22A6MAPTLMNATHRB
SCHEMBL18494822 0.76 FGFR1 (0.35) FGFR1SLC22A6MAPTLMNATHRB
SCHEMBL8840757 0.75 FGFR1 (0.35) FGFR1SLC22A6MAPTXIAPBIRC2
SCHEMBL12096477 0.75 FGFR1 (0.39) FGFR1SLC22A6ALDH1A1MAPTPOLB
SCHEMBL8371869 0.74 FGFR1 (0.34) FGFR1SLC22A6MAPTLMNATHRB
SCHEMBL22402203 0.74 FGFR1 (0.34) FGFR1SLC22A6MAPTLMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8859490-B2 Peptide nucleic acid monomers and oligomers NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-10-14 US disclosed
US-20120065364-A2 PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065364-A2 PEPTIDE NUCLEIC ACID MONOMERS AND OLIGOMERS SIN3A, POLR2H, CYTH3 FGFR1 1776/4885HPGD 4559/4885SLC22A6 3170/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.